What is the gut microbiome?
The gut microbiome is the community of microorganisms — mostly bacteria — living primarily in your large intestine. No two people share the same microbial makeup; it's shaped by genetics, birth method, diet, medications (especially antibiotics), environment and age. Researchers often describe microbiome health in terms of diversity — how many different microbial species are present — since low diversity is consistently associated with several chronic conditions in observational research.
What do gut bacteria actually do?
One of the best-understood mechanisms is fermentation: gut bacteria break down dietary fiber your own digestive enzymes can't process, producing short-chain fatty acids (SCFAs) as byproducts.
Does diet change your microbiome?
Yes — but a 2021 Stanford trial produced a genuinely surprising result that complicates the simple "eat more fiber" narrative. Over 10 weeks, healthy adults were assigned to either a high-fiber diet or a diet rich in fermented foods (yogurt, kefir, kimchi, kombucha and similar).
The fermented-food group saw a measurable increase in microbiome diversity and a broad reduction in inflammatory markers. The high-fiber group did not show a cohort-wide increase in diversity over the same period — despite fiber's reputation as the default recommendation for gut health.
This doesn't mean fiber is unimportant — it remains well established for digestive and cardiovascular health through other mechanisms — but it's a useful reminder that "more fiber, more diversity" is a simplification the evidence doesn't fully support, at least over this timeframe.
Is the gut microbiome responsible for everything?
This is where hype outruns evidence most often. It helps to separate three tiers of confidence:
Gut bacteria ferment fiber into SCFAs that measurably affect gut-barrier integrity and immune signaling.
Microbiome composition differs, on average, between people with and without conditions from obesity to mood disorders, in observational studies.
Whether those differences are a cause, a consequence, or a bystander — and whether shifting the microbiome reliably changes outcomes for most people.
What does current research show?
Fecal microbiota transplantation is a genuinely established microbiome therapy
For recurrent C. difficile infection, transplanting stool from a healthy donor restores microbial diversity and resolves infection at high rates — in one meta-analysis of patients with inflammatory bowel disease, 80% after a single treatment and 90% after repeat treatment.
This is a narrow, well-defined clinical indication. It's genuine evidence that deliberately altering the microbiome can treat disease — but it doesn't generalize to the much broader wellness claims made about microbiome interventions for other conditions.
A major 2025 review consolidates what SCFAs do — and don't yet explain
Short-chain fatty acids have well-characterized effects on gut-barrier integrity, immune cell signaling and metabolic regulation, established primarily through mechanistic and preclinical work.
The review notes that translating these mechanisms into reliable, reproducible clinical benefit in humans — via diet, supplements or targeted therapies — remains an active area of research rather than a settled matter.
What remains uncertain
- Which microbiome changes are causes of disease versus consequences of it?
- Why do probiotic strains that work in one study fail to replicate in another?
- How much individual variability in microbiome composition affects the "right" diet for a given person?
- Will larger, longer, more diverse trials confirm the fermented-food findings seen in smaller studies?
Interested in digestive health?
See how we think about formulation science for ingredients relevant to this system — why we chose specific forms, dosages and excipients.
References & Further Reading
- Gut microbiota-derived short-chain fatty acids and their role in human health and disease.
- Gut-microbiota-targeted diets modulate human immune status.
- Outcomes of Fecal Microbiota Transplantation for C. difficile Infection in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.